Back

Ticagrelor monotherapy after percutaneous coronary intervention in patients with concomitant diabetes mellitus and chronic kidney disease: a TWILIGHT substudy

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Highlights from the Young in Intervention Adjunctive Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Davide Cao

Humanitas University, Milan (Italy)

4 More presentations in this session

Presentation thumbnail
Risk prediction in patients with classical Low-flow, low-gradient aortic stenosis undergoing TAVI
Doctor S. Ludwig (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Implications of ESC-high tthrombotic risk features and ARC-high bleeding risk criteria on clinical outcomes in all-comer patients undergoing PCI
Doctor H. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Long-term follow-up of early leaflet thrombosis after transcatheter aortic valve replacement
Doctor M. Hein (Bad Krozingen, DE)
Abstract Slides Video
Presentation thumbnail
Derivation and validation of a pretest probability score for deep vein thrombosis before surgery
Doctor Y. Hamamoto (Kagoshima, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Highlights from the Young in Intervention

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Percutaneous intervention is better than surgery in real life for most patients: pro
thumbnail
Congress Presentation
State-of-the-art lecture on adjunctive antiplatelet therapy for patients undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
Association of PCI with outcomes in stable coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources